Ultrasound-guided intra-articular Wharton's jelly MSC & exosome protocols for knee osteoarthritis
Stem cell therapy for knee arthritis in Istanbul, Turkey
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat reviews your knee X-rays and MRI to deliver targeted ultrasound-guided regenerative care.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Understanding the condition
Understanding the condition and our regenerative approach
Knee osteoarthritis can turn the most fundamental daily movements—walking down the street, climbing or descending stairs, rising from a chair, or enjoying active recreation—into sources of persistent aching, morning stiffness, and recurring joint swelling. Inside an osteoarthritic knee, the smooth hyaline cartilage cushion across the medial, lateral, or patellofemoral compartments is progressively degraded by catabolic enzymes (such as MMP-13 and aggrecanases), while an inflamed synovial membrane releases pro-inflammatory cytokines into the joint fluid and the underlying subchondral bone develops painful micro-edema under increased mechanical load. Left unchecked, this hostile intra-articular environment accelerates chondrocyte stress, weakens quadriceps activation, and narrows functional mobility.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes work directly inside the knee joint cavity to calm synovial inflammation, protect surviving chondrocytes, and restore a healthier biochemical microenvironment. When delivered into the knee, WJ-MSCs and their nanoscale exosomes downregulate pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 while polarizing synovial macrophages from a cartilage-degrading M1 state toward a reparative, anti-inflammatory M2 phenotype. Simultaneously, they secrete chondroprotective and angiogenic growth factors—such as TGF-β, IGF-1, VEGF, and tissue inhibitors of metalloproteinases (TIMPs)—while exosomal microRNAs and proteins penetrate the hyaline cartilage matrix and meniscal tissues to counter enzymatic breakdown, prevent chondrocyte apoptosis, and support synovial fluid lubrication and subchondral microcirculation.
At our Istanbul regenerative medicine clinic led by Uzm. Dr. Cihan Bolat, we carefully review your standing weight-bearing knee X-rays, MRI scans, Kellgren-Lawrence grade, and meniscus status to design a personalized treatment protocol. Our physicians deliver precisely dosed WJ-MSCs and concentrated WJ-MSC exosomes directly into one or both knee joints under real-time ultrasound guidance, adding systemic intravenous biological support when multi-joint or metabolic inflammation is present. By addressing the root inflammatory and catabolic drivers inside your knee, our goal is to reduce daily pain and swelling, improve walking and stair-climbing comfort, and support durable knee function alongside progressive rehabilitation.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
Key biological processes and therapeutic targets
Knee osteoarthritis is driven by an active biological cycle of synovial membrane inflammation, enzymatic breakdown of hyaline cartilage, and subchondral bone stress—processes directly targeted by intra-articular WJ-MSC and exosome therapy.
What our protocol aims to support
- Quieting intra-articular synovial inflammation: Ultrasound-guided WJ-MSC and exosome delivery aims to shift the knee's synovial fluid from a pro-inflammatory, catabolic state toward a calmer anti-inflammatory environment.
- Supporting resident chondrocytes & extracellular matrix: Paracrine growth factors (including TGF-β and IGF-1) and exosomal vesicles aim to protect surviving chondrocytes and support cartilage matrix maintenance.
- Improving walking comfort, stair mobility & knee stability: By calming joint effusion and capsular irritation, the protocol aims to reduce daily pain and help you engage more effectively in quadriceps and hip strengthening.
- Coordinated with your ongoing physical therapy & joint care: Your Istanbul knee program is integrated with customized load management, progressive rehabilitation exercises, and your home orthopedic care.
- 01
Hyaline cartilage matrix breakdown
The weight-bearing surfaces of the femur, tibia, and patella are lined by smooth hyaline cartilage composed of type II collagen fibers and water-binding aggrecan proteoglycans. In knee osteoarthritis, stressed chondrocytes and inflamed synovial cells overproduce matrix metalloproteinase-13 (MMP-13) and aggrecanases (ADAMTS-4/5), which cleave collagen networks and strip away the shock-absorbing cushion. Intra-articular WJ-MSCs and WJ-MSC exosomes counteract this degradation by secreting tissue inhibitors of metalloproteinases (TIMPs) alongside anabolic growth factors such as TGF-β and IGF-1. At the same time, nanoscale exosomes diffuse into the cartilage matrix to deliver regulatory microRNAs that suppress catabolic enzyme expression and support chondrocyte survival. This biological intervention helps protect remaining hyaline cartilage and supports extracellular matrix maintenance.
- 02
Chronic synovitis & joint effusion
Even in early and moderate knee osteoarthritis, cartilage breakdown fragments irritate the synovial membrane, activating M1 macrophages and synoviocytes to release TNF-α, IL-1β, IL-6, and prostaglandins into the joint fluid. This chronic synovitis causes recurring knee swelling ('water on the knee'), morning stiffness, warmth, and degraded hyaluronic acid lubrication. Delivered under ultrasound guidance, WJ-MSCs and exosomes release potent anti-inflammatory mediators including IL-10 and TGF-β that shift synovial macrophages from a destructive M1 state to a reparative M2 phenotype. Exosomal cargo further calms inflammatory signaling within synovial lining cells. As synovitis quiets down, joint effusion subsides and the synovial environment becomes far more comfortable for daily movement.
- 03
Subchondral bone sclerosis & marrow lesions
As cartilage shock absorption diminishes in the medial or lateral knee compartments, abnormal mechanical forces transmit directly into the underlying tibial and femoral subchondral bone. This overload triggers micro-fractures, abnormal bone thickening (sclerosis), microvascular congestion, and painful bone marrow lesions visible on MRI that cause deep aching when standing or climbing stairs. WJ-MSCs and WJ-MSC exosomes secrete angiogenic and osteo-modulatory factors—such as VEGF, IGF-1, and TGF-β—that support microvascular perfusion and balanced osteochondral remodeling. Paracellular and vesicular signaling also reduces inflammatory cross-talk across the calcified cartilage-bone interface. Supporting subchondral microcirculation and calming bone marrow stress helps relieve deep weight-bearing knee pain.
- 04
Meniscal & periarticular soft-tissue strain
Knee osteoarthritis rarely affects cartilage in isolation; degenerative fraying of the fibrocartilaginous menisci, joint capsule fibrosis, and pain-induced inhibition of the quadriceps muscle further destabilize knee biomechanics. Inflamed meniscal and capsular tissues release additional nociceptive signals that make deep knee bending or twisting painful. Intra-articular WJ-MSCs and exosomes bathe the meniscal margins and capsular lining in trophic growth factors (IGF-1, TGF-β, PDGF) and anti-inflammatory microRNAs that support fibrochondrocyte homeostasis and tissue elasticity. By easing capsular irritation and intra-articular pain, the protocol also reduces arthrogenic muscle inhibition. This allows patients to strengthen their quadriceps and hip stabilizers much more effectively during post-treatment rehabilitation.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Biological Repair Rationale for the Osteoarthritic Knee Cavity
Knee osteoarthritis is not passive mechanical wear alone; it is an active biochemical cascade where inflamed synoviocytes and macrophages flood the joint fluid with cytokines (IL-1β, TNF-α) and cartilage-digesting MMP enzymes. This inflammatory soup degrades type II collagen and sensitizes pain receptors across the joint capsule and subchondral bone. Regenerative therapy targets this root intra-articular inflammation and enzymatic imbalance directly inside the knee. By shifting the synovial fluid from a catabolic to a trophic environment, surviving chondrocytes can better maintain the cartilage cushion.
Synergistic Action of Wharton's Jelly MSCs & Exosomes
Wharton's jelly-derived MSCs (WJ-MSCs) and WJ-MSC exosomes work together inside the knee capsule through complementary cellular and vesicular repair mechanisms. Live WJ-MSCs provide sustained paracrine secretion of anti-inflammatory cytokines (IL-10, TGF-β), anabolic growth factors (IGF-1), and natural MMP blockers (TIMPs) that calm synovitis and polarize macrophages to the reparative M2 phenotype. In parallel, billions of nanoscale exosomes penetrate dense avascular hyaline cartilage and meniscal fibers to transfer regenerative microRNAs and protective proteins directly into stressed chondrocytes. This synergy supports both synovial fluid quality and extracellular matrix resilience.
Personalized Knee Grading & Ultrasound-Guided Precision in Istanbul
Before you travel, Uzm. Dr. Cihan Bolat and our Istanbul medical team evaluate your standing knee radiographs and MRI scans to assess your Kellgren-Lawrence grade, compartment alignment, and meniscal integrity. Using this evaluation, we customize the exact intra-articular WJ-MSC cell count and exosome concentration for one or both knees, and determine whether systemic intravenous support is beneficial. Every knee injection in Istanbul is performed under real-time ultrasound visualization to guarantee accurate placement inside the synovial cavity. This rigorous diagnostic and procedural precision sets realistic goals and optimizes your functional recovery.
Our treatment approach & administration routes
How our proposed Wharton's jelly MSC and exosome protocols work
- 01
Ultrasound-Guided Intra-Articular WJ-MSC Injection
This primary route places Wharton's jelly mesenchymal stem cells (WJ-MSCs) directly into the knee joint cavity under continuous, real-time ultrasound visualization. Ultrasound guidance guarantees that the cells bypass the infrapatellar fat pad and extra-articular tissues to enter the synovial space accurately, even in knees with narrowed joint space or osteophytes. Inside the knee capsule, WJ-MSCs respond to inflammatory signals by secreting IL-10, TGF-β, IGF-1, and TIMPs, polarizing synovial macrophages toward a reparative M2 phenotype and protecting hyaline cartilage chondrocytes from MMP-mediated breakdown. It is chosen because direct intra-articular placement delivers maximum biological concentration to the exact cartilage, meniscal, and synovial surfaces driving knee osteoarthritis.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 02
Ultrasound-Guided Intra-Articular Exosome Administration
Delivered directly into the knee capsule under ultrasound guidance alongside WJ-MSCs, concentrated WJ-MSC-derived exosomes supply billions of nanoscale extracellular vesicles rich in chondroprotective proteins and regulatory microRNAs. Because hyaline cartilage is dense and avascular, nanoscale exosomes are uniquely suited to diffuse through the extracellular matrix and enter stressed chondrocytes and meniscal fibrochondrocytes. Their molecular cargo downregulates catabolic MMP-13 and ADAMTS activity, supports type II collagen and proteoglycan synthesis, and calms synovial lining inflammation. Combining intra-articular exosomes with live WJ-MSCs provides both rapid vesicular repair signaling and sustained cellular paracrine support within the knee.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 03
Intravenous WJ-MSCs & Exosomes (When Systemic Support Is Included)
When patients present with bilateral knee osteoarthritis, concurrent hip or spine arthritis, or systemic metabolic inflammation, our physicians can pair intra-articular knee injections with an intravenous infusion of WJ-MSCs and exosomes. Circulating cells and vesicles lower systemic pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), promote regulatory T-cell balance, and support systemic microvascular endothelial health. Improving subchondral vascular perfusion and reducing whole-body low-grade inflammation helps reinforce the local reparative environment inside the treated knee joints. This combined approach is tailored during your pre-travel evaluation with Uzm. Dr. Cihan Bolat.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
What we aim to achieve
Therapeutic objectives and functional outcomes we track
Before treatment in Istanbul, our physicians establish your clinical baseline and define realistic biological and functional objectives to track during follow-up.
- 01
WOMAC & KOOS Knee Pain, Stiffness & Function Scores
By quieting intra-articular TNF-α and IL-1β synovitis and inhibiting cartilage-degrading MMP enzymes, our protocol aims to produce meaningful improvements on validated WOMAC and KOOS knee scales. We track these standardized scores over follow-up checkpoints to measure your progress in daily comfort and joint function.
- 02
Walking Distance, Stair Climbing & Sit-to-Stand Ease
Supporting hyaline cartilage homeostasis (via TGF-β and IGF-1) and calming subchondral bone marrow stress helps reduce weight-bearing pain across the medial, lateral, and patellofemoral compartments. In daily life, this biological support helps you walk farther, navigate stairs more smoothly, and rise from chairs with greater confidence.
- 03
Reduction in Knee Swelling, Effusion & Morning Stiffness
Polarizing synovial macrophages from pro-inflammatory M1 to reparative M2 states calms chronic synovial lining irritation and excess fluid production. Patients notice less recurring knee tightness or swelling after daily walks and a shorter duration of morning stiffness.
- 04
Active Knee Range of Motion & Quadriceps Rehab Capacity
Easing intra-articular inflammation and capsular tension allows smoother active knee flexion and extension without sharp catching or aching. Reduced joint pain also lifts arthrogenic muscle inhibition, enabling you to build stronger quadriceps and hip muscles during physical therapy.
How treatment is personalized
How our medical team evaluates your records and designs your protocol
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat reviews your knee X-rays and MRI to deliver targeted ultrasound-guided regenerative care.
Medical history & reports we request
- Weight-bearing knee X-rays showing joint space and Kellgren-Lawrence grade
- Knee MRI report evaluating cartilage thickness, meniscus, and subchondral bone
- History of knee swelling, locking, ligament stability, and walking tolerance
- Prior hyaluronic acid, corticosteroid, or PRP injections and physical therapy
- Direct imaging review by Uzm. Dr. Cihan Bolat to confirm intra-articular protocol suitability
Clinical suitability & protocol checks
- Patients with mild-to-moderate osteoarthritis (grades 1–3) typically have the most favorable biological environment, whereas severe bone-on-bone deformity is reviewed candidly so you know whether orthopedic surgery at home is more appropriate.
- Both knees can be treated during the same outpatient session in Istanbul when bilateral knee osteoarthritis is present.
- We provide a clear post-injection timeline for gentle weight-bearing, travel home, and progressive quadriceps rehabilitation.
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
- 01
Contact us & share your medical reports
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
- 02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
- 03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
- 04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Transparent Istanbul pricing tailored to your protocol
After our medical team evaluates your records, we provide a written proposal explaining the recommended Wharton's jelly MSC and exosome preparations, administration routes, intended objectives, stay timeline, and itemized costs.
For 2026 planning context, targeted exosome and local orthopedic protocols typically range from $3,500–$6,500, while comprehensive Wharton's jelly MSC and exosome programs range from $7,000–$18,000. Your exact cost is confirmed after your medical evaluation.
- Patients with mild-to-moderate osteoarthritis (grades 1–3) typically have the most favorable biological environment, whereas severe bone-on-bone deformity is reviewed candidly so you know whether orthopedic surgery at home is more appropriate.
- Both knees can be treated during the same outpatient session in Istanbul when bilateral knee osteoarthritis is present.
- We provide a clear post-injection timeline for gentle weight-bearing, travel home, and progressive quadriceps rehabilitation.
What your written treatment proposal explains
- 01
Which Wharton's jelly MSC, exosome, or combined protocol is proposed for your condition?
- 02
Which administration routes are recommended and how do they work biologically?
- 03
What are the intended therapeutic objectives and expected stay length in Istanbul?
- 04
What is the itemized cost and how does 1, 3, and 6-month follow-up work after treatment?
Evidence & important considerations
Published clinical research and important considerations
Below is a summary of published human studies, investigated mechanisms, and important limitations relevant to regenerative medicine for this condition.
01 Culture-expanded MSC knee osteoarthritis phase 3 trial
Open study- Product
- Culture-expanded mesenchymal stromal cells
- Route
- Intra-articular knee injection
- Study design
- Randomized, double-blind, placebo-controlled multicenter phase 3 trial
- Finding
- In patients with Kellgren-Lawrence grade 3 knee osteoarthritis, intra-articular MSC administration produced statistically significant improvements in VAS pain and WOMAC functional scores compared with placebo at six months.
- Limitation
- Because clinical trials show strong symptom and functional gains without guaranteed bulk cartilage regrowth in advanced bone-on-bone loss, grading your knee beforehand is essential.
Scientific references
Clinical studies and scientific references
- Culture-expanded MSC knee osteoarthritis phase 3 trialAmerican Journal of Sports Medicine · Primary study
- Management of osteoarthritis of the knee guidelineAmerican Academy of Orthopaedic Surgeons · Clinical guideline
- Osteoarthritis clinical guidelineAmerican College of Rheumatology and Arthritis Foundation · Clinical guideline
FAQ
Frequently asked questions about this treatment
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.